Top member reports
Company Report
Last edited 12 months ago
PerformanceCommunity EngagementCommunity Endorsement
ranked
#45
Performance (91m)
4.9% pa
Followed by
174
Straws
Sort by:
Recent
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
#GREAT NEWS = NO NEWS = CONFUSI
stale
Added 12 months ago

Caught the back-end of what I thought to be a good news story a couple of days back but haven't seen or heard anything since which leaves me a little confused? I know there must be something I'm missing here so any additional info would be welcomed?

Even ACL hasn't released anything but I found the following this morning:


This new blood test finds melanoma before your eyes do, and it could be just months away.......


Australia is renowned for its sunny beaches and outdoor lifestyle, but with that comes a heightened risk of skin cancer. 

Melanoma, in particular, is a significant concern for Australians, with the country having one of the highest rates of skin cancer in the world. Early detection is crucial, as it can mean the difference between a simple surgical procedure and a life-threatening condition. 

A groundbreaking development from Melbourne scientists could revolutionise how we detect melanoma, potentially saving thousands of lives each year.

The new blood test is designed to detect the presence of melanoma before it becomes visible to the naked eye, catching the disease at its earliest and most treatable stage. This innovative test measures specific biomarkers associated with cancer, and researchers are touting an impressive 97 per cent accuracy rate in distinguishing between benign moles and various stages of melanoma. 

The test is particularly promising for those at high risk of melanoma, including individuals with a family history of the disease, those with fair skin, or anyone with a significant history of sun exposure or sunburn.

The test was developed by Genesq Biosciences and pathology provider Australian Clinical Labs (ACL).

It’s important to note that while the test is on the cusp of becoming available, it is not yet covered by government healthcare programs. This means that, initially, the cost could be between $1,200 and $1,500 per test, potentially putting it out of reach for some Australians.


#ASX Announcements
stale
Added 3 years ago

Monday, 20 March 2023

ACL INVESTOR WEBINAR Australian Clinical Labs Limited (ASX: ACL) (ACL or Company) today announced its intention to make an offmarket takeover bid to acquire all of the fully paid ordinary shares on issue in Healius Limited (ASX:HLS).  

#Financials
stale
Added 3 years ago

If you've been waiting for an entry point....today just might provide the opportunity....plus added bonus of a juicy FF div.